Pharmaceuticals Companies By Operating Margin

Operating Margin
Operating MarginEfficiencyMarket RiskExp Return
1AMLX Amylyx Pharmaceuticals
61.13
 0.02 
 4.71 
 0.08 
2SIGA SIGA Technologies
0.7
(0.01)
 2.57 
(0.02)
3RPRX Royalty Pharma Plc
0.61
 0.19 
 2.06 
 0.38 
4NVO Novo Nordisk AS
0.5
(0.10)
 2.86 
(0.29)
5INVA Innoviva
0.49
(0.01)
 0.91 
(0.01)
6LPCN Lipocine
0.44
(0.10)
 4.22 
(0.44)
7LLY Eli Lilly and
0.43
 0.06 
 2.06 
 0.11 
8CRMD CorMedix
0.41
 0.00 
 6.81 
 0.01 
9MRK Merck Company
0.34
(0.10)
 1.82 
(0.17)
10ZTS Zoetis Inc
0.33
 0.00 
 1.65 
 0.00 
11PBH Prestige Brand Holdings
0.32
 0.07 
 2.38 
 0.16 
12NVS Novartis AG ADR
0.3
 0.19 
 1.36 
 0.26 
13HRMY Harmony Biosciences Holdings
0.28
 0.00 
 3.04 
 0.00 
14WVE Wave Life Sciences
0.27
(0.08)
 4.08 
(0.34)
15AMPH Amphastar P
0.24
(0.19)
 2.33 
(0.45)
16COLL Collegium Pharmaceutical
0.24
 0.03 
 2.67 
 0.08 
17PRGO Perrigo Company PLC
0.24
 0.06 
 3.07 
 0.17 
18BHC Bausch Health Companies
0.23
(0.04)
 2.86 
(0.11)
19AZN AstraZeneca PLC ADR
0.23
 0.17 
 1.16 
 0.19 
20BMY Bristol Myers Squibb
0.23
 0.05 
 1.64 
 0.08 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations. A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.